Latest KFF Health News Stories
Experimental Stem Cell Treatment Leaves Three Women Blind
Researchers, who detail the women’s experiences in the New England Journal of Medicine, say it exposes the need for better regulation of clinical trials.
Congressman’s Ties To Foreign Biotech Draw Criticism
Rep. Chris Collins’ enthusiastic investments in Australian biotech company Innate Immunotherapeutics preceded share purchases by the Buffalo Republican’s family members, associates and political donors — raising questions from Washington, D.C., to Sydney.
Beware Of Unapproved Stem Cell Treatments
Pricey and unproven therapies that sound too good to be true probably are.
When Drug Reviewers Leave The FDA, They Often Work For Pharma
Researchers examine the Food and Drug Administration’s “revolving door” regarding employees who worked on cancer and hematology drugs.
Warning: Government Listing Of Clinical Trials Doesn’t Disclose Costs To Patients
Some clinics on NIH’s website charge people to participate in testing of unproven treatments — and it can come as a surprise to unsuspecting patients.
California is the first state to begin building an up-to-date database to improve the diagnosis and treatment of cancer.
NIH’s Fauci On Combating Zika: ‘You Have To Have The Resources To Act Quickly’
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, recently spoke with KHN’s Carmen Heredia Rodriguez about vaccine development and the ongoing fight in Congress over emergency funding.
Study Finds Doctors Quick To Change Practice For Breast Cancer Patients
Despite the usual view that physicians are slow to alter their routines based on new scientific evidence, researchers found that breast cancer surgeons quickly adopted advice to not remove lymph nodes after a landmark clinical trial in 2011.
American ‘Stem Cell Tourists’ Don’t Have To Travel Abroad, Study Says
Treatments marketed as everything from anti-aging applications to therapies for degenerative diseases are increasingly available at commercial clinics in the U.S., but their growing numbers raise ethical and regulatory concerns in the scientific community.
FDA Eases Paperwork To Help Some Patients Get Experimental Drugs
The Food and Drug Administration has introduced a simplified form that doctors will use to seek FDA approval to treat seriously ill patients with experimental drugs after other options run out.
Want Into A Clinical Trial? Read This First.
Experimental drugs might help desperate patients, but don’t count on an easy cure.
NIH Isn’t Ensuring That Clinical Trials Account For Different Outcomes By Sex
Clinical trials should look at whether men and women are affected differently, but the NIH isn’t holding researchers accountable, a new report says.
Researchers Say Their Path To Better Health Starts With Patients’ Input
A federal institute created by the health law is seeding research projects around the U.S. that connect medical professionals with patients to find better treatments.
Costs May Keep Low-Income Patients From Clinical Trials, Study Finds
Insurance generally covers routine costs patients encounter in a clinical trial, but the patients can still be responsible for co-payments and other expenses, such as lost wages and travel.
Contraceptive Implant Under Microscope Amid Questions of Safety, Altered Trial Data
Essure has generated more than 5,000 complaints of serious side effects.
